Lab Results
What Is an Optimal LH Level?
LH (luteinizing hormone) is the pituitary signal that triggers ovulation and testosterone production — yet most lab reports only flag it as abnormal when it's far outside a wide reference range. Understanding where your LH sits relative to cycle phase, age, and other hormones is what actually matters for fertility, energy, and long-term hormonal health.

What Is an Optimal LH Level?
For most adults, an optimal LH level falls between 1–18 IU/L depending on sex and menstrual cycle phase — but "in range" on a standard report tells you almost nothing. LH is only meaningful when read alongside FSH, estradiol, progesterone, and testosterone. The main exception: post-menopausal women and men with primary hypogonadism, where LH is expected to run persistently high.
What LH Actually Does — and Why the Number Alone Is Misleading
Luteinizing hormone is a glycoprotein secreted by the anterior pituitary in response to gonadotropin-releasing hormone (GnRH) pulses from the hypothalamus. In women, a sharp LH surge — typically reaching 25–40 IU/L or higher — triggers ovulation roughly 36 hours later. In men, LH acts on Leydig cells in the testes to stimulate testosterone synthesis. Because LH operates in pulses, a single blood draw can look normal even when underlying secretion is dysregulated.
This is one reason clinicians often order LH alongside FSH: the LH:FSH ratio provides far more signal than either value alone. A ratio greater than 2:1 or 3:1 is one of the diagnostic criteria for polycystic ovary syndrome (PCOS), for example — even when both hormones sit within the broad population reference range (Balen et al., Human Reproduction Update 2016; PMID: 26543896).
Reference Range vs. Optimal Range: What the Research Shows
Laboratory reference ranges for LH are built from population distributions, not from outcomes data. The table below shows typical reference intervals alongside the narrower "functional" windows that reproductive endocrinologists and integrative clinicians use when optimizing hormonal health.
| Population | Standard Lab Reference | Functional Optimal Window |
|---|---|---|
| Women — follicular phase | 1.9–12.5 IU/L | 3–9 IU/L |
| Women — LH surge (ovulatory) | 8.7–76.3 IU/L | Peak > 20 IU/L confirms ovulation |
| Women — luteal phase | 0.5–16.9 IU/L | 1–8 IU/L |
| Women — postmenopause | 10.0–54.7 IU/L | Expected high; context-dependent |
| Men (adults) | 1.7–8.6 IU/L | 3–7 IU/L alongside morning total T > 500 ng/dL |
| Children (prepubertal) | < 0.2 IU/L | < 0.2 IU/L |
These functional windows are not static cutoffs — they are decision thresholds that prompt a clinician to look more carefully at the broader hormonal picture. A man with LH of 8.4 IU/L (technically "in range") paired with total testosterone of 250 ng/dL warrants investigation for primary testicular failure; the elevated-normal LH is the pituitary working hard to compensate for poor gonadal response.
High LH: What It Can Signal
Persistently elevated LH — outside of the ovulatory surge window — generally points to one of three patterns:
- Primary hypogonadism (hypergonadotropic hypogonadism): The gonads are not responding adequately to LH stimulation, so the pituitary secretes more. In women, this is the hallmark of premature ovarian insufficiency (POI) or menopause. In men, it can indicate Klinefelter syndrome, testicular damage from infection or torsion, or age-related decline.
- PCOS: Elevated tonic LH (not a surge, but a chronically high baseline) with an LH:FSH ratio > 2 is a supporting finding in PCOS, driven by altered GnRH pulse frequency (McCartney & Marshall, New England Journal of Medicine 2016; PMID: 26735993).
- Ovarian reserve decline: Rising FSH and LH in the early follicular phase (days 2–4 of the cycle) can precede a formal menopause diagnosis by years and correlate with diminishing egg quality.
If your LH is trending high and you're interested in understanding how cholesterol metabolism intersects with sex hormone production, the article on what causes total cholesterol to be out of range is worth reading — cholesterol is the precursor substrate for all steroid hormones, including estrogen and testosterone.
Low LH: What It Can Signal
Suppressed LH points to problems upstream — at the hypothalamus or pituitary — rather than at the gonads themselves. This is called hypogonadotropic hypogonadism (HH) or secondary hypogonadism.
Common causes include:
- Functional hypothalamic amenorrhea (FHA): Chronic energy deficit, excessive exercise, or psychological stress suppresses GnRH pulsatility, dropping LH and FSH. Studies show LH pulse frequency and amplitude are both reduced in athletes with FHA relative to eumenorrheic controls (De Souza et al., Journal of Clinical Endocrinology & Metabolism 2010; PMID: 20534753).
- Hyperprolactinemia: Elevated prolactin inhibits GnRH release, secondarily blunting LH.
- Exogenous androgen/estrogen use: Anabolic steroids and hormonal contraceptives suppress the HPG axis, driving LH toward undetectable levels.
- Pituitary adenoma or structural lesion: Mass effect on the pituitary can impair gonadotropin secretion across the board.
In men, low LH with low testosterone is the defining pattern of secondary hypogonadism and is an important distinction because it changes the treatment pathway entirely — exogenous testosterone suppresses LH further, whereas clomiphene or HCG stimulates endogenous LH production.
LH in Context: The Hormones You Should Test Alongside It
Ordering LH in isolation is like reading one sentence from a paragraph. The markers below complete the picture:
| Companion Marker | Why It Matters With LH |
|---|---|
| FSH | LH:FSH ratio defines PCOS pattern; rising FSH signals ovarian reserve decline |
| Estradiol (E2) | Low E2 + high LH = primary ovarian failure; high E2 mid-cycle = impending ovulation |
| Testosterone (total + free) | In men, high LH + low T = primary hypogonadism |
| Prolactin | Elevated prolactin suppresses LH — rule out before attributing low LH to other causes |
| DHEA-S | Adrenal androgen; helps distinguish adrenal vs. gonadal androgen excess |
| SHBG | Determines how much testosterone is bioavailable; relevant when interpreting LH drive |
| AMH (women) | Ovarian reserve marker independent of cycle phase; pairs with FSH/LH picture |
Insulin resistance is another critical modifier of LH that is often overlooked. Hyperinsulinemia directly stimulates LH secretion and amplifies LH-driven androgen production in the ovaries, which is a core mechanism in PCOS (Dunaif, Endocrine Reviews 1997; PMID: 9402274). This is why metabolic markers — including optimal fasting insulin level — belong in the same workup as reproductive hormones when the clinical picture is complex.
LH and the Broader Metabolic Picture
Sex hormones and metabolic health are deeply intertwined. Testosterone decline in men is associated with insulin resistance, dyslipidemia, and increased cardiovascular risk. Estrogen decline in women accelerates LDL oxidation and shifts lipid profiles unfavorably — which is why tracking optimal HDL cholesterol level becomes increasingly important as LH rises toward post-menopausal ranges.
Blood sugar regulation also intersects directly with hormonal balance. Women with PCOS — a condition often characterized by elevated LH — have significantly higher rates of impaired glucose tolerance. Tracking what is an optimal A1C level alongside LH and FSH gives a much fuller picture of cardiometabolic risk in this population.
The LH–lipid connection runs in both directions: estrogen supports favorable HDL metabolism, so as LH rises and ovarian estrogen output falls, lipid profiles frequently worsen. Tracking optimal triglycerides level alongside hormonal markers offers a more complete cardiometabolic risk assessment, particularly in perimenopausal women.
How LH Is Measured — and the Timing Problem
LH testing has two reliable windows:
- Basal measurement (days 2–4 of the menstrual cycle for women): Reflects the tonic, non-surge secretion rate and allows direct comparison against follicular phase reference ranges.
- Surge detection: Either via daily urine LH strips (OPKs) or serial blood draws around cycle day 12–14. Serum LH at the peak is used clinically to time insemination or IVF trigger shots.
For men, LH can be drawn at any time of day, though morning draws are preferred because testosterone — and its feedback on LH — follows a diurnal pattern. A single random LH draw in a woman outside of days 2–4 or the surge window is nearly uninterpretable without simultaneous estradiol and progesterone values.
Point-of-care urine LH strips are convenient for cycle tracking but are designed to detect a surge, not to quantify basal levels. For diagnostic purposes, serum immunoassay remains the standard.
What This Means for Your Formula
Ones does not include exogenous hormones — no LH analogs, no testosterone precursors, and no estrogen mimetics. What it does is support the upstream systems that regulate LH secretion and downstream signaling.
When a user's lab work and health history point to HPA-HPG axis dysregulation — the stress-hormone-reproductive axis crossover — Ones may include:
- Ashwagandha (KSM-66, 600 mg): Randomized controlled trials show KSM-66 reduces serum cortisol by approximately 27% in chronically stressed adults and has been shown to significantly improve testosterone levels in men with subfertility in an 8-week trial (Wankhede et al., Evidence-Based Complementary and Alternative Medicine 2015; PMID: 26609282). By reducing cortisol-mediated suppression of GnRH, adaptogen support can help normalize LH pulsatility in stress-suppressed individuals.
- Vitamin D3 + K2 (MK-7): Vitamin D receptors are expressed on pituitary gonadotroph cells. Low vitamin D status correlates with lower LH and FSH in subfertile women, and supplementation at 2,000–4,000 IU/day has been associated with improved follicular development in observational studies. Ones pairs D3 with MK-7 to support calcium metabolism simultaneously.
- Adrenal Support (proprietary blend): For users whose low LH pattern is driven by functional hypothalamic suppression from chronic stress, Ones' Adrenal Support system blend addresses the upstream HPA dysregulation rather than chasing the LH number directly.
The Ones AI evaluates your complete hormonal and metabolic lab picture — not just a single value — to determine which ingredients and blends belong in your 6- or 9-capsule daily formula. If LH dysregulation is part of a broader picture that includes insulin resistance or lipid changes, those findings are factored into the same formula, not treated in isolation.
Key Takeaways
- LH reference ranges are wide by design — they reflect population distributions, not optimal hormonal function. An LH value "in range" can still indicate meaningful imbalance when read alongside FSH, estradiol, and testosterone.
- High LH (outside of ovulatory surge) points to primary gonadal failure, ovarian reserve decline, or — in women with elevated LH:FSH ratio — PCOS. Low LH points to hypothalamic or pituitary suppression.
- Timing matters enormously: a basal LH measured on cycle days 2–4 is diagnostically useful; a random mid-cycle draw without companion markers is nearly uninterpretable.
- Insulin resistance amplifies LH-driven androgen production in PCOS — metabolic markers like fasting insulin and A1C belong in any comprehensive hormonal workup.
- Sex hormone decline reshapes cardiometabolic risk: as estrogen falls and LH rises, lipid profiles, triglycerides, and cardiovascular risk markers shift — making integrated lab review more valuable than hormone panels alone.
- Upstream support matters more than chasing the LH number: adaptogenic, adrenal, and vitamin D support can help normalize the axis environment. Consult a reproductive endocrinologist or endocrinologist before initiating any hormone-directed therapy.
---
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making decisions about hormone testing or supplementation.